Skip to main content
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2001 May-Jun;7(3):448–450. doi: 10.3201/eid0703.010315

Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.

E J Threlfall 1, L R Ward 1
PMCID: PMC2631792  PMID: 11384525

Abstract

In 1999, 23% of Salmonella enterica serotype Typhi isolates from patients in the United Kingdom exhibited decreased susceptibility to ciprofloxacin (MIC 0.25-1.0 mg/L); more than half were also resistant to chloramphenicol, ampicillin, and trimethoprim. Increasing numbers of treatment failures have been noted. Most infections have been in patients with a recent history of travel to India and Pakistan.

Full Text

The Full Text of this article is available as a PDF (44.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson E. S., Smith H. R. Chloramphenicol resistance in the typhoid bacillus. Br Med J. 1972 Aug 5;3(5822):329–331. doi: 10.1136/bmj.3.5822.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hampton M. D., Ward L. R., Rowe B., Threlfall E. J. Molecular fingerprinting of multidrug-resistant Salmonella enterica serotype Typhi. Emerg Infect Dis. 1998 Apr-Jun;4(2):317–320. doi: 10.3201/eid0402.980223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Murdoch D. A., Banatvaia N., Bone A., Shoismatulloev B. I., Ward L. R., Threlfall E. J., Banatvala N. A. Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan. Lancet. 1998 Jan 31;351(9099):339–339. doi: 10.1016/s0140-6736(05)78338-0. [DOI] [PubMed] [Google Scholar]
  4. Paniker C. K., Vimala K. N. Transferable chloramphenicol resistance in Salmonella typhi. Nature. 1972 Sep 8;239(5367):109–110. doi: 10.1038/239109b0. [DOI] [PubMed] [Google Scholar]
  5. Parry C., Wain J., Chinh N. T., Vinh H., Farrar J. J. Quinolone-resistant Salmonella typhi in Vietnam. Lancet. 1998 Apr 25;351(9111):1289–1289. doi: 10.1016/s0140-6736(05)79356-9. [DOI] [PubMed] [Google Scholar]
  6. Rowe B., Threlfall E. J., Ward L. R. Does chloramphenicol remain the drug of choice for typhoid? Epidemiol Infect. 1987 Jun;98(3):379–383. doi: 10.1017/s0950268800062142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Rowe B., Ward L. R., Threlfall E. J. Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis. 1997 Jan;24 (Suppl 1):S106–S109. doi: 10.1093/clinids/24.supplement_1.s106. [DOI] [PubMed] [Google Scholar]
  8. Rowe B., Ward L. R., Threlfall E. J. Treatment of multiresistant typhoid fever. Lancet. 1991 Jun 8;337(8754):1422–1422. doi: 10.1016/0140-6736(91)93116-q. [DOI] [PubMed] [Google Scholar]
  9. Threlfall E. J., Ward L. R., Skinner J. A., Smith H. R., Lacey S. Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet. 1999 May 8;353(9164):1590–1591. doi: 10.1016/s0140-6736(99)01001-6. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES